Wordt geladen...
3-Methyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl 4-aminobenzoate
The crystal structure of the title compound, C(18)H(13)NO(4), the oxidized form of the drug aminaftone used in venous disease therapy, is characterized by the presence of ribbons of hydrogen-bonded molecules parallel to the [111] crystallographic direction and by stacking interactions between ring...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
International Union of Crystallography
2008
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2961024/ https://ncbi.nlm.nih.gov/pubmed/21202108 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1107/S1600536808005308 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|